Foundation Medicine
Transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease.
Launch date
Employees
Market cap
-
Enterprise valuation
$54—81m (Dealroom.co estimates Jan 2013.)
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $7.0m | Early VC | |
$33.5m | Series A | ||
| N/A | $42.5m | Series B | |
$13.5m | Series B | ||
| N/A | N/A | IPO | |
| N/A | N/A | Acquisition | |
| Total Funding | $96.5m | ||
Related Content
Recent News about Foundation Medicine
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
